John R. Wingard

Active 1973–2025

Also published as
John R Wingard
186
Papers
61,374
Citations
108
h-index
182
i10-index

Citations

Citations per year for John R. Wingard1976: 2 citations1979: 1 citations1980: 4 citations1981: 2 citations1982: 6 citations1983: 1 citations1984: 5 citations1985: 10 citations1986: 6 citations1987: 11 citations1988: 12 citations1989: 29 citations1990: 30 citations1991: 40 citations1992: 48 citations1993: 52 citations1994: 60 citations1995: 74 citations1996: 80 citations1997: 81 citations1998: 110 citations1999: 133 citations2000: 137 citations2001: 151 citations2002: 193 citations2003: 216 citations2004: 222 citations2005: 242 citations2006: 262 citations2007: 315 citations2008: 337 citations2009: 361 citations2010: 430 citations2011: 465 citations2012: 425 citations2013: 385 citations2014: 449 citations2015: 394 citations2016: 447 citations2017: 369 citations2018: 314 citations2019: 1,391 citations2020: 1,437 citations2021: 1,279 citations2022: 798 citations2023: 605 citations2024: 1,151 citations2025: 447 citations2026: 9 citations1977–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,556 citing papers, 27.4% of this breakdownGermany: 987 citing papers, 6% of this breakdownUnited Kingdom: 966 citing papers, 5.8% of this breakdownFrance: 955 citing papers, 5.8% of this breakdownItaly: 770 citing papers, 4.6% of this breakdownChina: 736 citing papers, 4.4% of this breakdownSpain: 636 citing papers, 3.8% of this breakdownNetherlands: 604 citing papers, 3.6% of this breakdownCanada: 573 citing papers, 3.5% of this breakdownAustralia: 478 citing papers, 2.9% of this breakdownSwitzerland: 424 citing papers, 2.6% of this breakdownJapan: 386 citing papers, 2.3% of this breakdown
0%27.4%Other 27.3%

Fields

  • Medicine87.6%
  • Biochemistry, Genetics and Molecular Biology4.1%
  • Immunology and Microbiology3.1%
  • Health Professions1.1%
  • Psychology0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Other2.6%

Topics

  • Antifungal resistance and susceptibility13.4%
  • Fungal Infections and Studies9.5%
  • Hematopoietic Stem Cell Transplantation7.8%
  • Neutropenia and Cancer Infections4%
  • Acute Myeloid Leukemia Research2.1%
  • Cytomegalovirus and herpesvirus research2.1%
  • Other61.1%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 2,822

  3. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2005 cited by 3,530

  4. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theoklis E. Zaoutis, John E. Bennett - Clinical Infectious Diseases 2008 cited by 4,909

  5. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 3,427

  6. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 1,442

  7. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason E. Hill, Stanley C. Gill, Rishita Nuthethi, Denise King, Heather Wittsack, Adam Mendizabal, Steven M. Devine, Mary M. Horowitz, Yi‐Bin Chen, on behalf of the BMT-CTN 1506/MORPHO Study Investigators, Ed Agura, Jessica K. Altman, Achiles Anagnostopoulos, Sarah Anand, Andrew Artz, Walter E. Aulitzky, Sophia Balderman, Karen K. Ballen, Michael W. Becker, Yves Béguin, Leanne Berkahn, Zwi Berneman, Vijaya Raj Bhatt, Ian Bilmon, Francesca Bonifazi, Adrienne Briggs, Benedetto Bruno, Claudio G. Brunstein, Michael Byrne, Jenny Byrne, Mónica Cabrero, Roberto Cairoli, George Carrum, Jan Černý, Yi‐Bin Chen, June‐Won Cheong, Fabio Ciceri, Mercedes Colorado, Rachel J. Cook, Daniel R. Couriel, Charles Craddock, Lloyd E. Damon, Abhinav Deol, Yohan Desbrosses, Steve Devine, Carmela Di Grazia, Antonio Di Stasi, Ajoy Dias, Kathy Dorritie, James Essell, Tetsuya Eto, Sherif S. Farag, Édouard Forcade, Olga Frankfurt, Shin‐ichiro Fujiwara, Takahiro Fukuda, Kentaro Fukushima, Sabine Fürst, Tatsunori Goto, Aric C. Hall, Shunsuke Hatta, Yosr Hicheri, Mitchell E. Horwitz, Hsin‐An Hou, Jonathan How, Dianna S. Howard, Wei‐Hsun Hsu, Anne Huynh, David Irvine, Takayuki Ishikawa and 109 more - Journal of Clinical Oncology 2024 cited by 185

  8. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

    Authors: , , , , , , , , - Biology of Blood and Marrow Transplantation 2009 cited by 1,779

  9. Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 3,297

  10. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 547

  11. Combination Antifungal Therapy for Invasive Aspergillosis

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2015 cited by 500

  12. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 905

  13. First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

    Authors: , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2012 cited by 645

  14. Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 627

  15. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2008 cited by 460

  16. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy

    Authors: , , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2016 cited by 393

  17. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2008 cited by 2,703

  18. Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Emerging infectious diseases 2011 cited by 319

  19. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

    Authors: , , , , , , , , , , , , , , , , , , , , , , - 1998 cited by 568

  20. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

    Authors: , , , , , , , , , , , , , - Blood 2011 cited by 592

  21. Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2011 cited by 706

  22. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 376

  23. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors

    Authors: , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 169

  24. PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis

    Authors: , , , , , , , , , , , , , - Journal of Clinical Microbiology 2018 cited by 113